<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-molecules-25-05514">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Caridha</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Vesely</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>van Bocxlaer</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Arana</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Mowbray</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Rafati</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Uliana</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Reguera</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kreishman-Deitrick</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sciotti</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis</article-title>
  <source>IJP Drugs Drug Resist.</source>
  <year>2019</year>
  <volume>11</volume>
  <fpage>106</fpage>
  <lpage>117</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijpddr.2019.06.003</pub-id>
 </element-citation>
</ref>
